Circulating miR-200c and miR-141 and Outcomes in Patients With Breast Cancer

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1238-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2015English

Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer

Asian Pacific Journal of Cancer Prevention
2019English

Regulation of miR-200c/141 Expression by Intergenic DNA-looping and Transcriptional Read-Through

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2016English

Plasma Level of miR-21 and miR-451 in Primary and Recurrent Breast Cancer Patients

Breast Cancer: Targets and Therapy
Oncology
2019English

UTMD Inhibit EMT of Breast Cancer Through the ROS/miR-200c/ZEB1 Axis

Scientific Reports
Multidisciplinary
2020English

Overexpression of Circulating MiR-30b-5p Identifies Advanced Breast Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Clinical Significance of miR-140-5p and miR-193b Expression in Patients With Breast Cancer and Relationship to IGFBP5

Genetics and Molecular Biology
GeneticsMolecular Biology
2015English

miR-200c: A Versatile Watchdog in Cancer Progression, EMT, and Drug Resistance

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2016English

Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy